Article citationsMore>>
Matsumoto, H., Shiotani, A., Katsumata, R., Fujita, M., Nakato, R., Murao, T., Ishii, M., Kamada, T., Haruma, K. and Graham, D.Y. (2016) Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. Digestive Diseases and Sciences, 61, 3215-3220.
https://doi.org/10.1007/s10620-016-4305-0
has been cited by the following article:
-
TITLE:
Gastric Mucosal Atrophy Might Be Associated with the Efficacy of First-Line Therapy Using Vonoprazan for Helicobacter pylori
AUTHORS:
Mika Miura, Masahiko Ohtaka, Mitsuhiko Hanawa, Naoki Shimura, Yoshioki Yoda, Sho Suzuki
KEYWORDS:
Vonoprazan, Eradication, Helicobacter pylori, Propensity Score Matching, Gastric Mucosal Atrophy
JOURNAL NAME:
Open Journal of Gastroenterology,
Vol.7 No.9,
September
28,
2017
ABSTRACT: Aim: To investigate the factors related to the effect of eradication therapy with vonoprazan for Helicobacter pylori (H. pylori). Methods: We retrospectively reviewed medical records of H. pylori-positive patients who received first-line (40 mg vonoprazan/60 mg lansoprazole or 20 mg rabeprazole, 1500 mg amoxicillin, 400 mg clarithromycin, all 2/day for 7 days) (n = 4118). H. pylori eradication was assessed by the 13C-urea breath test with success defined as a result of H. pylori eradication therapy using vonoprazan was more effective than standard triple therapy with proton pump inhibitor. Gastric mucosal atrophy was associated with treatment success.
Related Articles:
-
R. Douglas Martin, Shengyu Zhang
-
Xiaochun Mei
-
Flavio Gimenes Alvarenga, Mahouton Jonas Stephane Houndjo, Adjimon Vincent Monwanou, Jean Bio Chabi Orou
-
Yun Sun, Minghui Yang, Hengrong Cui, Minhua Chen, Yukun Zhu, Xiaowei Sun
-
Yuka Satoh, Hatsue Ogawara, Osamu Kawamura, Yasuyuki Shimoyama, Motoyasu Kusano, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Norifumi Tsukamoto, Hirokazu Murakami